96 related articles for article (PubMed ID: 11146367)
1. Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone.
Ng FM; Sun J; Sharma L; Libinaka R; Jiang WJ; Gianello R
Horm Res; 2000; 53(6):274-8. PubMed ID: 11146367
[TBL] [Abstract][Full Text] [Related]
2. The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice.
Heffernan M; Summers RJ; Thorburn A; Ogru E; Gianello R; Jiang WJ; Ng FM
Endocrinology; 2001 Dec; 142(12):5182-9. PubMed ID: 11713213
[TBL] [Abstract][Full Text] [Related]
3. Increase of fat oxidation and weight loss in obese mice caused by chronic treatment with human growth hormone or a modified C-terminal fragment.
Heffernan MA; Thorburn AW; Fam B; Summers R; Conway-Campbell B; Waters MJ; Ng FM
Int J Obes Relat Metab Disord; 2001 Oct; 25(10):1442-9. PubMed ID: 11673763
[TBL] [Abstract][Full Text] [Related]
4. Effects of oral administration of a synthetic fragment of human growth hormone on lipid metabolism.
Heffernan MA; Jiang WJ; Thorburn AW; Ng FM
Am J Physiol Endocrinol Metab; 2000 Sep; 279(3):E501-7. PubMed ID: 10950816
[TBL] [Abstract][Full Text] [Related]
5. Molecular and cellular actions of a structural domain of human growth hormone (AOD9401) on lipid metabolism in Zucker fatty rats.
Ng FM; Jiang WJ; Gianello R; Pitt S; Roupas P
J Mol Endocrinol; 2000 Dec; 25(3):287-98. PubMed ID: 11116208
[TBL] [Abstract][Full Text] [Related]
6. Antilipogenic action of synthetic C-terminal sequence 177-191 of human growth hormone.
Wu Z; Ng FM
Biochem Mol Biol Int; 1993 May; 30(1):187-96. PubMed ID: 8358331
[TBL] [Abstract][Full Text] [Related]
7. Reduction of cumulative body weight gain and adipose tissue mass in obese mice: response to chronic treatment with synthetic hGH 177-191 peptide.
Natera SH; Jiang WJ; Ng FM
Biochem Mol Biol Int; 1994 Aug; 33(5):1011-21. PubMed ID: 7987248
[TBL] [Abstract][Full Text] [Related]
8. Effect of an antilipogenic fragment of human growth hormone on glucose transport in rat adipocytes.
Wijaya E; Ng FM
Biochem Mol Biol Int; 1993 Nov; 31(3):543-52. PubMed ID: 8118430
[TBL] [Abstract][Full Text] [Related]
9. Increased sensitivity of adipose tissue to insulin after in vivo treatment of yellow Avy/A obese mice with amino-terminal peptides of human growth hormone.
Frigeri LG; Teguh C; Ling N; Wolff GL; Lewis UJ
Endocrinology; 1988 Jun; 122(6):2940-5. PubMed ID: 3131129
[TBL] [Abstract][Full Text] [Related]
10. Different growth hormone-receptor interactions mediate insulin-like and lipolytic responses of rat adipose tissue.
Chipkin SR; Szecowka J; Tai LR; Kostyo JL; Goodman HM
Endocrinology; 1989 Jul; 125(1):450-8. PubMed ID: 2500331
[TBL] [Abstract][Full Text] [Related]
11. The 20-kD human growth hormone reduces body fat by increasing lipolysis and decreasing lipoprotein lipase activity.
Takahashi S; Satozawa N
Horm Res; 2002; 58(4):157-64. PubMed ID: 12324712
[TBL] [Abstract][Full Text] [Related]
12. Diabetogenic activity of 20 kDa human growth hormone (20K-hGH) and 22K-hGH in rats.
Takahashi S; Shiga Y; Satozawa N; Hayakawa M
Growth Horm IGF Res; 2001 Apr; 11(2):110-6. PubMed ID: 11472077
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone and lipolysis: a reevaluation.
Goodman HM; Grichting G
Endocrinology; 1983 Nov; 113(5):1697-702. PubMed ID: 6354693
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of the lipolytic activity of adipocytes isolated from white adipose tissue in Zucker and Wistar rats. In vitro effects of 3,5,3'-triiodo-L-thyronine].
Loireau A; Chomard P; Autissier N; Dumas P
C R Seances Soc Biol Fil; 1986; 180(4):441-6. PubMed ID: 2948624
[TBL] [Abstract][Full Text] [Related]
15. [Biphasic action of human growth hormones, of hypophyseal origin or bacterial production, on the lipolysis of rat adipocytes in vitro].
Elsair J; Khelfat K; Aoul MT; Ghouini A
Ann Endocrinol (Paris); 1985; 46(6):389-97. PubMed ID: 3915423
[TBL] [Abstract][Full Text] [Related]
16. A recombinant-DNA-derived modification of human growth hormone (hGH44-191) with enhanced diabetogenic activity.
Lewis UJ; Lewis LJ; Salem MA; Staten NR; Galosy SS; Krivi GG
Mol Cell Endocrinol; 1991 Jun; 78(1-2):45-54. PubMed ID: 1936524
[TBL] [Abstract][Full Text] [Related]
17. Expression, purification, and lipolytic activity of recombinant human serum albumin fusion proteins with one domain of human growth hormone in Pichia pastoris.
Wang F; Wu M; Liu W; Shen Q; Sun H; Chen S
Biotechnol Appl Biochem; 2013; 60(4):405-11. PubMed ID: 23750891
[TBL] [Abstract][Full Text] [Related]
18. Biological activity of bacterial derived human growth hormone in adipose tissue of hypophysectomized rats.
Goodman HM
Endocrinology; 1984 Jan; 114(1):131-5. PubMed ID: 6690268
[TBL] [Abstract][Full Text] [Related]
19. Hypoglycemic action of a novel constrained analog of human growth hormone-(6-13).
Lim N; Ng FM; Wu ZM; Ede N; Hearn MT
Endocrinology; 1992 Aug; 131(2):835-40. PubMed ID: 1639027
[TBL] [Abstract][Full Text] [Related]
20. Tofogliflozin Improves Insulin Resistance in Skeletal Muscle and Accelerates Lipolysis in Adipose Tissue in Male Mice.
Obata A; Kubota N; Kubota T; Iwamoto M; Sato H; Sakurai Y; Takamoto I; Katsuyama H; Suzuki Y; Fukazawa M; Ikeda S; Iwayama K; Tokuyama K; Ueki K; Kadowaki T
Endocrinology; 2016 Mar; 157(3):1029-42. PubMed ID: 26713783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
